Gastric inhibitory polypeptide (GIP) antigen arrays and uses thereof
AssigneeCytos Biotechnology AG
InventorsMartin F. Bachmann, Alma Fulurija, Philippe Saudan
Life of this patent
Estimating the term…
Loading patent…
AssigneeCytos Biotechnology AG
InventorsMartin F. Bachmann, Alma Fulurija, Philippe Saudan
Estimating the term…
The present invention is in the fields of medicine, public health, immunology, molecular biology and virology. The present invention provides, inter alia, a composition comprising a virus-like particle (VLP) and at least one antigen, wherein said antigen is a GIP protein or a GIP fragment linked to the VLP respectively. The invention also provides a method for producing the aforesaid composition. The compositions of this invention are useful in the production of vaccines, in particular, for the prevention and/or treatment of obesity and hereby, in particular, by inducing efficient immune responses, in particular antibody responses. Furthermore, the compositions of the invention are particularly useful to efficiently induce self-specific immune responses within the indicated context. Accordingly, the invention further provides for methods of treating and/or preventing obesity and other conditions.
A composition comprising:
(canceled)
-6. (canceled)
(canceled)
-24. (canceled)
(canceled)
(canceled)
-33. (canceled)
Dependencies are inferred from the claim text.